Physician profile
Kendall E Hansen
NPI 1417952722
$3,169.35
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $954 · 2020: $1,050 · 2021: $1,106 · 2022: $41.72 · 2023: $17.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $544.11 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $392.22 | 2019-2021 | |
| Nevro Corp. | $300.91 | 2019-2020 | |
| Abbott Laboratories | $269.13 | 2019-2020 | |
| Boston Scientific Corporation | $220.75 | 2020 | |
| Amgen INC. | $191.64 | 2019-2022 | |
| Medtronic USA, INC. | $168.01 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $138.51 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $112.62 | 2019-2021 | |
| Medtronic, INC. | $104.48 | 2021-2023 | Intellis Adaptivestim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $99.71 | 2020-2021 | |
| Si-Bone, INC. | $74.14 | 2019-2020 | |
| Vertos Medical, INC. | $72.76 | 2020-2022 | |
| Scilex Pharmaceuticals INC. | $67.98 | 2019-2020 | |
| Abbvie INC. | $59.10 | 2021-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mdd US Operations, LLC | $38.42 | 2019-2020 | |
| Daiichi Sankyo INC. | $38.08 | 2019 | |
| Redhill Biopharma INC. | $35.10 | 2020 | |
| Lundbeck LLC | $34.56 | 2020-2021 | |
| Almatica Pharma LLC | $29.91 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $27.83 | 2021 | |
| Pfizer INC. | $25.33 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $24.65 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $14.52 | 2019 | |
| Zyla Life Sciences, INC. | $13.81 | 2020 | |
| Flowonix Medical Incorporated | $12.93 | 2020 | |
| Arbor Pharmaceuticals, INC. | $12.65 | 2021 | |
| Allergan, INC. | $12.45 | 2020 | |
| Lilly USA, LLC | $11.80 | 2021 | |
| Horizon Therapeutics Plc | $10.86 | 2019 | |
| Spr Therapeutics, INC | $10.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kendall Hansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.